AsclepiX Therapeutics
Baltimore, MD
AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maint... Read more
asclepix.comCompany Details
Founded
- 2011
Employees
- Between 5 - 20 employees
Raised
- $50,000,000
Headquarters Location
- Baltimore, MD
Public
- No
Acquired
- No
CEO
Robert Dempsey
Founders
- Aleksander S. PopelJordan Green
Company Collections
These are collections AsclepiX Therapeutics is a part of. Click on the collection name to view similar companies.
AsclepiX Therapeutics' Industries
Company Collections For AsclepiX Therapeutics
AsclepiX Therapeutics Headquarters Location
301 W 29th St suite 2004, Baltimore, MD MD 21211
Total Amount Raised: $50,000,000
AsclepiX Therapeutics Funding Rounds
Series A
$10,000,000
Series A Investors
Perceptive AdvisorsRapha Capital ManagementHibiscus Capital ManagementSeries A
$35,000,000
Series A Investors
Perceptive AdvisorsRapha Capital ManagementBarer & Son CapitalConvertible Note
$5,000,000
Convertible Note Investors
Barer & Son CapitalTEDCOPiedmont Capital PartnersSalem PartnersRapha Capital Management
Funding info provided by Diffbot.
AsclepiX Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AsclepiX Therapeutics.